News

Empassion's Recognition Marks a Milestone in Digital Health

Empassion's Recognition Marks a Milestone in Digital Health

Empassion Recognized in New York Digital Health 100

Empassion Health, the leading managed care provider, has earned a distinguished spot in the 2025 New York Digital Health 100 (DH100). This recognition is a testament to Empassion’s commitment to delivering exceptional care for adults living with serious illnesses, ensuring they enjoy the best quality of life possible.

Acknowledgement of Innovative Care

The 2025 DH100 list celebrates the most groundbreaking early-stage companies in New York as identified by Digital Health New York (DHNY). This acknowledgment comes not just as a pat on the back but as an official recognition of the transformative impact that Empassion is making in the healthcare arena.

Leadership Insights

Robin Heffernan, CEO of Empassion, articulated the pride the team feels in being recognized for their hard work. He stated, "The outstanding business performance at Empassion is driving the kind of formal validation we are receiving today," emphasizing the importance of their unique care model for American patients. This model focuses on high-quality care that significantly enhances the lives of those with serious illnesses.

Impactful Achievements

In recent years, particularly in 2024, Empassion achieved remarkable milestones. Here are some significant outcomes that underline their commitment to quality healthcare:

  • Hospitalization Reduction: Empassion successfully reduced hospitalizations by 50%, providing thousands of Americans with compassionate care in their preferred environments.
  • Access to Support: The organization facilitated high-quality supportive care to various populations, ensuring equitable access irrespective of geographic location.
  • Expanded Patient Coverage: They increased the number of patients served by an impressive five-fold across various insurance programs, including Medicare and Medicaid.
  • High Patient Satisfaction: Empassion's commitment is reflected in a stunning 95% satisfaction rate among patients and their families.
  • Cost Efficiency Achievements: In their 2023 impact announcement, the company highlighted a 25% reduction in care costs, achieving significant savings within Medicare.

Workforce and Operational Excellence

Empassion operates in an extensive network across 45 states, collaborating with an abundant range of community-based supportive care providers. This extensive network allows them to cater to numerous patient populations, including Original Medicare, Medicare Advantage, dual-eligible, and commercial clients.

Looking to the Future

The journey of Empassion is marked not only by their network and numbers but also by their innovative strategies that aim to set new benchmarks in managing chronic care for serious illness patients. Their sustained focus on delivering value-based, patient-centered care significantly enhances both patient outcomes and overall healthcare efficiency.

About Empassion

Empassion is more than just a healthcare provider; it represents a mission-driven approach towards offering high-quality care designed for adults facing serious illnesses. Their goal is to maximize the quality of life for their patients, ensuring every day is a good day.

Frequently Asked Questions

What is the significance of being named in the New York Digital Health 100?

Being named to the New York Digital Health 100 signifies that Empassion is recognized for its innovative practices and contributions to the digital health landscape, showcasing its ability to improve patient care effectively.

How does Empassion improve patient care?

Empassion enhances patient care by providing compassionate support and reducing hospitalizations, thereby allowing patients to receive treatment in the comfort of their own homes.

What impact has Empassion achieved in 2024?

In 2024, Empassion achieved a significant reduction in hospitalizations, increased patient coverage five-fold, and maintained a high satisfaction rate among its patients.

What types of populations does Empassion serve?

Empassion caters to various populations, including those covered under Original Medicare, Medicare Advantage, dual-eligible programs, and private commercial insurance.

How does Empassion strive for cost efficiency?

Empassion actively works to reduce the overall cost of care, having reported a 25% reduction in 2023, which resulted in substantial savings within Medicare. This approach ensures that patients receive top-quality care while minimizing unnecessary expenses.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 243

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 183

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 105

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
Greenberg Traurig's Brad Kaufman: A Mentor of Resolute Impact

Updated Category News Views 315

A Milestone for Mentorship at Greenberg Traurig In the often cutthroat jungle of law, finding someone who actually gives a damn about you is as rare as finding a unicorn. Yet, there it is—Brad Kaufman, at the helm of Greenberg Traurig's professional development, proving that mentorship can be more than just a checkbox on a quarterly review. Award for Exceptional...

Continue Reading
BETR's Slide: Investors Face Big Losses, Leadership Shift

Updated Category News Views 113

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 234

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 244

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 108

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 223

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading

Top 5 Most Recently Viewed Articles

WTW's Strategic Acquisitions: A Leap into the Future of Insurance

Updated Category News Views 178

WTW Expands Through Innovative Acquisitions Willis Towers Watson Public Ltd., known as WTW, is making headlines with its ambitious strategy to enhance its technology-enabled insurance and workplace benefits services. By announcing two consequential acquisitions, WTW aims to broaden its reach in the middle market while modernizing its client interactions significantly....

Continue Reading
Microsoft Faces Competition After Downgrade from D.A. Davidson

Updated Category News Views 120

Microsoft's Recent Downgrade by Analysts Analysts at D.A. Davidson have made headlines by downgrading Microsoft's (NASDAQ: MSFT) rating from Buy to Neutral. They have kept a price target of $475, reflecting ongoing evaluations of Microsoft's market strategies and performance. Factors Contributing to the Downgrade A key reason for this downgrade is the increasing...

Continue Reading
Portman Ridge Finance Faces Market Challenges with PTMN Stock

Updated Category News Views 133

Portman Ridge Finance Corporation Stock Overview In the current economic landscape, Portman Ridge Finance Corporation (NASDAQ: PTMN) has seen its stock touch a 52-week low, now priced at $16.19. This significant drop highlights a shift in investor sentiment, with key indicators such as the Relative Strength Index (RSI) signaling that the stock may be oversold. Notably,...

Continue Reading
Miami International Holdings Sees Growth in July Trading

Updated Category News Views 135

Miami International Holdings Reports Trading Results Miami International Holdings, Inc., a technology-driven leader in financial markets, has announced significant trading results for July 2025. The company operates several exchanges, including MIAX, MIAX Pearl, MIAX Emerald, MIAX Sapphire, and MIAX Futures. These results demonstrate a capacity for growth and stability in...

Continue Reading
Intel's Game-Changing Innovations at CES 2025 Unveiled

Updated Category News Views 220

Unveiling Innovations at CES 2025 At a highly anticipated event in Las Vegas, Intel took the stage at CES 2025 to reveal its latest technological advancements in mobile computing and edge solutions. With the launch of the new Intel Core Ultra (Series 2) processors, Intel is set to lead the charge in revolutionizing the way businesses, creators, and gaming enthusiasts...

Continue Reading